Alamar Biosciences, Inc.
Alamar Biosciences, Inc. scores highest on Anchor (68) and lowest on Price (12). Its PosiPenta is 48.06 out of 100, around the middle of similar companies.
On the Penta Grid this week, Alamar Biosciences, Inc. is Grid #315 of 837 in the Healthcare sector in United States, and Grid #2,108 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Alamar Biosciences, Inc. | 48.06 | 12 | 54 | 62 | 44 | 68 |
| Surgery Partners, Inc. | 51.44 | 38 | 72 | 59 | 47 | 42 |
| Zymeworks Inc. | 45.90 | 3 | 60 | 79 | 40 | 47 |
| Vera Therapeutics, Inc. | 34.47 | 14 | 28 | 45 | 37 | 48 |
| Harmony Biosciences Holdings, Inc. | 71.27 | 65 | 87 | 86 | 68 | 50 |
| Inspire Medical Systems, Inc. | 58.30 | 61 | 51 | 50 | 76 | 53 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -21.07 |
| P/B ratio | 5.61 |
EEarnings
| Trailing EPS | ₹-113.66 |
| Forward EPS | ₹-42.79 |
NNitro
| Price | 2394.39 |
| 52-week high | 3751.66 |
| 52-week low | 1785.38 |
| Fall from 52-week high | 36.2% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | 0.16 |
AAnchor
| Beta (price swings) | — |
| Market cap | ₹16,615 Cr |
| Insider holding | 22.24% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Alamar Biosciences, Inc.'s PosiPenta score?
Alamar Biosciences, Inc.'s PosiPenta is 48.06 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Alamar Biosciences, Inc. stand on the Penta Grid?
On the Penta Grid this week, Alamar Biosciences, Inc. is Grid #315 of 837 in the Healthcare sector in United States, and Grid #2,108 of 4,000 in United States.
Which PosiPenta pillar is strongest for Alamar Biosciences, Inc.?
Anchor (stability and dividends), with a score of 68 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Alamar Biosciences, Inc.?
Price (valuation), with a score of 12 out of 100: much weaker than most similar companies.
Has Alamar Biosciences, Inc.'s PosiPenta changed since last week?
Yes, it rose 1.99 points, from 46.07 to 48.06.
PositoAI is for research and education only and is not investment advice.